Biotech

Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada

D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.

|ByREUTERS
Medications. Ilustrative.
Jerusalem Mayor Moshe Lion, IATI CEO and President Karin Mayer Rubinstein and Teva executive Mark Sabag attend the opening of MIXiii Health-Tech.IL 2026 in Jerusalem.

Israeli health-tech conference opens in Jerusalem with 1,800 participants from 40 countries

MIXiii Health-Tech.IL 2026 brought together investors, doctors, researchers, startups and global health-tech leaders, with a focus on Israeli emergency medicine, tech-bio, and technologies.

|ByJERUSALEM POST STAFF
In the photo (from left): Karin Mayer Rubinstein, CEO and President of the Israel Advanced Technology Industries Association (IATI), and Dror Bin, CEO of the Israel Innovation Authority.

Israeli life sciences investments fell 40% in 2025, report found

Investments in Israeli life sciences companies fell sharply in 2025, dropping 40% after a recovery the previous year, according to a report by the Israel Advanced Technology Industries Association.

|ByJERUSALEM POST STAFF
The four-story ‘Clore Person, with inflatable organs that are activated by climbing inside the giant statue

Startup wants to grow “headless humans” to replace lab animals

Researchers describe brainless, lab-grown human bodies engineered to host full organ systems and study disease without consciousness.

|ByJERUSALEM POST STAFF

‘Cell-based, innovative products for a better future’

Pluristem’s proprietary cell-based technology platform develops cutting-edge therapies and cultured food materials

MARCH 10, 2022ByLIOR NOVIK
IN COLLABORATION with the Tnuva Group, Pluristem will develop raw material for the cultured meat market.

Reimagining the future of food

Israel’s northern Galilee has become the new go-to destination for food-tech start-ups

MARCH 1, 2022ByJENNIFER KORN
Planteam’s plant protein made without fillers, binders, mediators, gluten, additives, preservatives, or GMO

3D bioprinting tech to be licensed by Tel Aviv University

The technology was used to print a heart made of human cells and extracellular matrix at TAU in 2019.

FEBRUARY 4, 2022ByJERUSALEM POST STAFF
A 3D printed, small-scaled human heart engineered from the patient’s own materials and cells.

New method for mapping gene expression could be used alongside cancer therapy - study

Findings by Israeli scientists may completely change the way we approach observing the biological processes of the human body in the future.  

JANUARY 31, 2022ByJERUSALEM POST STAFF
Bar-Shir team - Dr. Amnon Bar-Shir and Dr. Hyla Allouche-Arnon

Israeli biotech company paves a new way in healing injured spinal cords

The company successfully used human implants for replacing the injured spinal cord of a living pig, thereby simulating the anticipated surgical procedure in humans.

JANUARY 12, 2022ByJERUSALEM POST STAFF
Piglets at a pig farm.